Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 24 (BNIP3P24)

Target
BNIP3P24
Molecular classification
Other (Pseudogene)
01

Overview

BNIP3P24 is a pseudogene related to the BCL2 interacting protein 3 (BNIP3) gene but does not produce a functional protein in humans. Pseudogenes like BNIP3P24 are typically non-functional genomic DNA sequences resembling known genes. While the BNIP gene family plays important roles in apoptosis and autophagy, with members like BNIP3 and BNIP3L acting as pro-apoptotic proteins, BNIP3P24 itself does not encode any functional protein and is not a therapeutic target. Consequently, it does not have biological functions, disease associations, or known drug interactions. Its designation as a pseudogene means it does not participate in cellular signaling or serve as a biomarker for disease. No evidence indicates BNIP3P24 is incorrectly labeled as a therapeutic target; rather, it fits the pattern of multiple identified BNIP3-related pseudogenes, which are generally functionally inert.

Other names
BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 24BNIP3P24

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 24 (BNIP3P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 24 (BNIP3P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call